Segment Information

Management has concluded that Life Sciences, which is focused on growth in the medical end market, primarily in the orthopaedics and medical/surgical end markets; Mobile Solutions, which is focused on growth in the general industrial and automotive end markets; and Power Solutions, which is focused on growth in the electrical and aerospace and defense end markets, constitute our operating segments. Life Sciences, Mobile Solutions, and Power Solutions are considered operating segments as each engages in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the Chief Operating Decision Maker (“CODM”) reviews discrete financial information for purposes of allocating resources and assessing performance.

Segment Results

The following tables present results of operations by reportable segment.



	Life Sciences		Mobile Solutions		Power Solutions		Corporate and Consolidations				Total
Three Months Ended September 30, 2019
Net sales	$	94,011	$	73,071	$	47,430	$	(615	)	(a)	$	213,897
Income (loss) from operations	9,402		3,681		3,351		(8,762		)		7,672
Interest expense											(14,733		)
Other											(98		)
Loss before benefit for income taxes and share of net income from joint venture											$	(7,159	)
Three Months Ended September 30, 2018
Net sales	$	78,363	$	81,805	$	46,082	$	(567	)	(a)	$	205,683
Income (loss) from operations	6,717		4,657		2,706		(8,199		)		5,881
Interest expense											(18,608		)
Other											(6,932		)
Loss before benefit for income taxes and share of net income from joint venture											$	(19,659	)



	Life Sciences		Mobile Solutions		Power Solutions		Corporate and Consolidations				Total
Nine Months Ended September 30, 2019
Net sales	$	271,351	$	230,590	$	148,480	$	(1,602	)	(a)	$	648,819
Income (loss) from operations	22,553		11,880		12,857		(30,919		)		16,371
Interest expense											(42,492		)
Other											(3,583		)
Loss before provision for income taxes and share of net income from joint venture											$	(29,704	)
Nine Months Ended September 30, 2018
Net sales	$	168,716	$	259,678	$	144,584	$	(1,798	)	(a)	$	571,180
Income (loss) from operations	12,962		21,822		13,939		(39,440		)		9,283
Interest expense											(46,592		)
Other											(21,444		)
Loss before benefit for income taxes and share of net income from joint venture											$	(58,753	)

_______________________________


(a)	Includes elimination of intersegment transactions occurring during the ordinary course of business.

Total assets by reportable segment as of September 30, 2019, and December 31, 2018, were as follows:



	Total Assets
	September 30, 2019		December 31, 2018
Life Sciences	$	817,153	$	802,770
Mobile Solutions	377,571		356,387
Power Solutions	314,516		297,947
Corporate and Consolidations	44,505		45,797
Total	$	1,553,745	$	1,502,901